Yinson Annual Report 2020

185 Annual Report 2020 Employees’ Share Scheme (continued) The number of unissued shares granted under the ESS during the financial year and the number of unissued shares outstanding at the end of the financial year are as follows: (continued) Number of options over unissued ordinary shares Outstanding as at 1.2.2019 Granted Lapsed Outstanding as at 31.1.2020 Date of offer 22 January 2020 - first tranche - 1,246,666 - 1,246,666 - second tranche - 1,246,667 - 1,246,667 - third tranche - 1,246,667 - 1,246,667 - 3,740,000 - 3,740,000 No person to whom the option for unissued share has been granted as disclosed above has any right to participate by virtue of the option in any share issue of any other company. Directors The Directors in office during the financial year and during the period from the end of the financial year to the date of this report are: Lim Han Weng Lim Chern Yuan Bah Kim Lian Lim Han Joeh Dato’ Wee Hoe Soon @ Gooi Hoe Soon Dato’ Mohamad Nasir bin AB Latif Raja Datuk Zaharaton binti Raja Zainal Abidin Datuk Abdullah bin Karim Rohaya binti Mohammad Yusof (Appointed on 1 January 2020) Sharifah Munira bt. Syed Zaid Albar (Appointed on 1 January 2020) Directors’ benefits Neither during nor at the end of the financial year was the Company or any of its subsidiaries a party to any arrangements whose objects was to enable the Directors to acquire benefits by means of the acquisition of shares in, or debentures of, the Company or any other body corporate other than share options granted under the ESS. Since the end of the previous financial year, no Director has received or become entitled to receive a benefit (other than benefits included in the aggregate amount of remuneration received or due and receivable by the Directors as shown in Note 11 to the financial statements) by reason of a contract made by the Company or a related corporation with the Director or with a firm of which the Director is a member, or with a company in which the Director has a substantial financial interest, except as disclosed in Note 38 to the financial statements.